Clinical Trial Update: Camrelizumab Combined With Apatinib in the Treatment of Patients With Advanced Gastric Cancer and Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating camrelizumab plus apatinib in advanced colorectal cancer (recurrent).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Apatinib (apatinib)
• Camrelizumab (camrelizumab)

Snippet

Sponsor: Zhongshan Hospital Xiamen University | Conditions: Colorectal Cancer Recurrent | Phase 1, Phase 2 | Status: UNKNOWN